M/I Homes (MHO) is Trading Higher on Unusual Volume for February 04

Equities Staff |

M/I Homes (MHO) experienced unusually high volume on Feb. 04, as the stock gained 0.06% to a closing price of $17.05. The stock saw 377,556 shares trade hands over the course of the day on 3,081 trades. Given that the stock’s average daily volume over the last month has been 208,644 shares a day, this represents a pretty substantial spike over the norm.

M/I Homes has a P/B ratio of 0.79. It also has a P/E ratio of 11.5. The stock has traded between $27.00 and $16.63 over the last 52-weeks, its 50-day SMA is now $20.57, and its 200-day SMA $23.24.

M/I Homes Inc is a builder of single-family homes. It also provides financial services to support its homebuilding operations by providing mortgage loans and title services to the customers.

Headquartered in Columbus, OH, M/I Homes has 905 employees and is currently under the leadership of CEO Robert H. Schottenstein / Paul S. Rosen.

For a complete fundamental analysis analysis of M/I Homes, check out Equities.com’s Stock Valuation Analysis report for MHO. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…


D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…